Growth Metrics

Gilead Sciences (GILD) Retained Earnings (2016 - 2026)

Gilead Sciences filings provide 17 years of Retained Earnings readings, the most recent being $39.0 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 70.45% to $39.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.0 million, a 70.45% decrease, with the full-year FY2025 number at $39.0 million, down 70.45% from a year prior.
  • Retained Earnings hit $39.0 million in Q4 2025 for Gilead Sciences, up from $36.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $16.9 billion in Q3 2021 to a low of -$20.0 million in Q1 2023.
  • Median Retained Earnings over the past 5 years was $5.4 billion (2024), compared with a mean of $7.3 billion.
  • Biggest five-year swings in Retained Earnings: skyrocketed 73391.3% in 2021 and later tumbled 119.35% in 2025.
  • Gilead Sciences' Retained Earnings stood at $83.0 million in 2021, then surged by 18800.0% to $15.7 billion in 2022, then tumbled by 99.82% to $28.0 million in 2023, then skyrocketed by 371.43% to $132.0 million in 2024, then crashed by 70.45% to $39.0 million in 2025.
  • The last three reported values for Retained Earnings were $39.0 million (Q4 2025), $36.0 million (Q3 2025), and -$18.0 million (Q2 2025) per Business Quant data.